SCHEMBL700108

SCHEMBL700108

COC(=O)c1cc2ccccc2s1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.68
ALDH1A1 P00352 2/20 0.64
HPGD P15428 1/20 0.64
HDAC1 Q13547 2/20 0.64
HDAC3 O15379 1/20 0.64
HDAC4 P56524 1/20 0.64
HDAC7 Q8WUI4 1/20 0.64
HDAC2 Q92769 1/20 0.64
HDAC10 Q969S8 1/20 0.64
HDAC11 Q96DB2 1/20 0.64
HDAC8 Q9BY41 1/20 0.64
HDAC6 Q9UBN7 1/20 0.64
HDAC9 Q9UKV0 1/20 0.64
HDAC5 Q9UQL6 1/20 0.64
RAB9A P51151 1/20 0.54
TAS1R3 Q7RTX0 2/20 0.53
TAS1R1 Q7RTX1 2/20 0.53
SLC9A1 P19634 2/20 0.53
CNR1 P21554 1/20 0.51
CNR2 P34972 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29445494 1.00 BCL2L1 (0.68) BCL2L1ALDH1A1HPGDHDAC1HDAC3
SCHEMBL25306019 0.86 BCL2L1 (0.59) BCL2L1ALDH1A1HPGDHDAC1HDAC3
SCHEMBL9431835 0.86 ALDH1A1 (0.60) BCL2L1ALDH1A1HPGDHDAC1HDAC3
SCHEMBL9431168 0.86 BCL2L1 (0.51) BCL2L1ALDH1A1HPGDHDAC1HDAC3
SCHEMBL29758083 0.83 BCL2L1 (0.59) BCL2L1ALDH1A1HPGDHDAC1HDAC3
SCHEMBL7626224 0.83 HDAC3 (0.60) BCL2L1ALDH1A1HPGDHDAC1HDAC3
SCHEMBL25233727 0.82 BCL2L1 (0.54) BCL2L1ALDH1A1HPGDHDAC1HDAC3
SCHEMBL19756723 0.82 BCL2L1 (0.62) BCL2L1ALDH1A1HPGDHDAC1HDAC3
SCHEMBL4405770 0.81 BCL2L1 (0.57) BCL2L1ALDH1A1HPGDHDAC1HDAC3
SCHEMBL25214651 0.81 BCL2L1 (0.57) BCL2L1ALDH1A1HPGDHDAC1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111841896-A Benzo-heterocycle hydroximic acid collecting agent and preparation method and application thereof 武汉工程大学 2020-10-30 CN claimed
CN-118715206-A Novel HDAC inhibitors and therapeutic uses thereof 探戈医药股份有限公司 2024-09-27 CN disclosed
CN-117813295-A Compounds targeting p53 mutants 北京加科思新药研发有限公司 2024-04-02 CN disclosed
CN-114072207-B Bicyclic compounds 维瓦斯治疗公司 2024-03-29 CN disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
CN-115160098-B Oxygen-containing compound deoxidization methylation method 中国科学院兰州化学物理研究所 2023-06-06 CN disclosed
CN-111841896-B Benzo-heterocycle hydroximic acid collecting agent and preparation method and application thereof 武汉工程大学 2022-10-18 CN disclosed
CN-115160098-A Oxygen-containing compound deoxidation and methylation method 中国科学院兰州化学物理研究所 2022-10-11 CN disclosed
CN-115003666-A Pesticidally active fused bicyclic heteroaromatic amino compounds 先正达农作物保护股份公司 2022-09-02 CN disclosed
US-20220162199-A1 BENZOTHIOPHENE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2022-05-26 US disclosed
US-5298630-A Reacting 2-alkylthiobenzaldehyde derivative with halo compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 1994-03-29 US disclosed
EP-0572712-A2 Processes for producing 2-substituted benzo(beta)thiophene SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 1993-12-08 EP disclosed
CN-1023013-C Process for preparing thianaphthene derivatives SANKYO CO (JP) 1993-12-08 CN disclosed
US-5244893-A Fungicides BAYER AKTIENGESELLSCHAFT (DE) 1993-09-14 US disclosed
EP-0267794-B1 PROCESS FOR PREPARING POLYOLEFINS Nippon Petrochemicals Co., Ltd. (JP) 1993-05-05 EP disclosed
EP-0267794-A2 Process for preparing polyolefins Nippon Petrochemicals Co., Ltd. (JP) 1988-05-18 EP disclosed
EP-0052471-B1 PROCESS AND CATALYST FOR POLYMERIZATION OF OLEFINS Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1985-09-18 EP disclosed
US-4526941-A Contacting alpha olefin with catalyst comprising organomagnesium compound, titanium compound, nitrogen or sulfur heterocyclic compound, slurry component and organometallic component ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-07-02 US disclosed
US-4525555-A TITANIUM COMPOUND SUPPORTED ON SOLID REACTION PRODUCT OF MAGNESIUM HALIDE, SILOXANES, ORGANIC COMPOUNDS NIPPON OIL COMPANY, LIMITED (JP) 1985-06-25 US disclosed
EP-0052471-A1 Process and catalyst for polymerization of olefins Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 BCL2L1 1966/4885ALDH1A1 4660/4885HPGD 4047/4885
US-20220162199-A1 BENZOTHIOPHENE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF STING1, CYP11B1, CYP4A11 BCL2L1 1258/4885ALDH1A1 3747/4885HPGD 1172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.